Investigational Drug Information for DWP14012
✉ Email this page to a colleague
What is the development status for investigational drug DWP14012?
DWP14012 is an investigational drug.
There have been 24 clinical trials for DWP14012.
The most recent clinical trial was a Phase 3 trial, which was initiated on June 2nd 2020.
The most common disease conditions in clinical trials are Esophagitis, Gastroesophageal Reflux, and Esophagitis, Peptic. The leading clinical trial sponsors are Daewoong Pharmaceutical Co. LTD., Sun Young, Kim, and Hanyang University.
Summary for DWP14012
| US Patents | 0 |
| International Patents | 33 |
| US Patent Applications | 16 |
| WIPO Patent Applications | 7 |
| Japanese Patent Applications | 2 |
| Clinical Trial Progress | Phase 3 (2020-06-02) |
| Vendors | 25 |
Recent Clinical Trials for DWP14012
| Title | Sponsor | Phase |
|---|---|---|
| Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non-Erosive Gastroesophageal Reflux Disease (NERD) | Daewoong Pharmaceutical Co. LTD. | Phase 3 |
| A Clinical Study to Investigate the Mass Balance and Biotransformation of [14C]DWP14012 in Healthy Chinese Male Subjects | Shanghai Haini Pharmaceutical Co., Ltd. | Phase 1 |
| A Clinical Study to Investigate the Mass Balance and Biotransformation of [14C]DWP14012 in Healthy Chinese Male Subjects | Daewoong Pharmaceutical Co. LTD. | Phase 1 |
Clinical Trial Summary for DWP14012
Top disease conditions for DWP14012
Top clinical trial sponsors for DWP14012
US Patents for DWP14012
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for DWP14012
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| DWP14012 | Australia | AU2016255308 | 2035-04-27 | ⤷ Sign Up |
| DWP14012 | Brazil | BR112017020056 | 2035-04-27 | ⤷ Sign Up |
| DWP14012 | Canada | CA2977750 | 2035-04-27 | ⤷ Sign Up |
| DWP14012 | Chile | CL2017002571 | 2035-04-27 | ⤷ Sign Up |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
